Amanda J. Driscoll

TL;DR: The findings, limited to exposure and immunoprophylaxis studies, do not support basing policy decisions on an assumption that prevention of RSV-LRTI will reduce recurrent chronic wheezing illnesses.

TL;DR: The evidence is inconclusive in establishing a causal association between RSV LRTI and RWEC/asthma, the evidence does not establish that RSV mAbs will have a substantial effect on these outcomes and regardless of the association with long-term childhood respiratory morbidity, severe acute RSV disease in young children poses a substantial public health burden.

TL;DR: In this paper, the authors evaluated country reports from 2018 on adult immunisation programs sent to the World Health Organization and UNICEF and used multivariable regression to identify independent factors associated with having them, such as high or upper-middle country income, introduction of new or underused vaccines, having achieved paediatric immunisation coverage goals and meeting National Immunisation Technical Advisory Group basic functional indicators.

TL;DR: This research presents a novel, scalable, scalable and scalable approach that can be applied to rapidly prototyping and large-scale applicability in the context of vaccine-preparedness and infection prevention.

TL;DR: In this article, the authors modeled age-specific and season-specific risks of respiratory syncytial virus lower respiratory tract infections within monthly cohorts of infants from birth to six months and calculated the incremental cost-effectiveness ratio of each intervention compared to status quo from the perspectives of the government, donor and society.